Drug intelligence / Profile preview

flurbiprofen

Development stage
Approved
Modality
Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class, structurally related to ibuprofen, fenoprofen, and ketoprofen. It is used primarily for the symptomatic treatment of osteoarthritis and rheumatoid arthritis, providing relief from pain, inflammation, swelling, stiffness, and joint pain. Flurbiprofen acts as a non-selective inhibitor of cyclooxygenase (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins involved in inflammation and pain. It is available as an oral tablet for systemic use and also in ophthalmic formulations for prevention or reduction of intraoperative miosis during ocular surgery. The S-enantiomer has both anti-inflammatory and antinociceptive effects via inhibition of prostaglandin biosynthesis; R-flurbiprofen exhibits antinociceptive activity but not significant anti-inflammatory action.

Brand names
Ansaid
Other names
(±)-2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid(RS)-2-(2-fluorobiphenyl-4-yl)propanoic acid5104-49-4FlubiprofenFlurbiprofeneFlurbiprofeno3-Fluoro-4-phenylhydratropic acidFlurbiprofenum(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid5GRO578KLPDTXSID0037231DTXSID-0037231DTXSID 0037231Fluriproben(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+-)-氟比洛芬
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on flurbiprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flurbiprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call